Sarah Ronnebaum

Sarah Ronnebaum is a seasoned research scientist with expertise in evidence synthesis and market access strategies. Currently serving at Evidera since April 2022, Sarah previously held leadership positions at OPEN Health Evidence & Access, where responsibilities included directing strategic market access initiatives. During a tenure at Deloitte, Sarah engaged with key federal health agencies and facilitated strategic recommendations through consultations. Academic experiences include a postdoctoral fellowship at the University of North Carolina at Chapel Hill, where original research was conducted in molecular biology, and graduate studies at Duke University, where a PhD in Pharmacology was earned. Notable achievements include numerous publications, conference presentations, and successful grant applications, alongside roles in mentoring and scientific editing.